NeurAxis Announces Participation in Upcoming Investor Conference
NeurAxis to Join Lytham Partners Fall Investor Conference
CARMEL, Ind. — NeurAxis, Inc. (NYSE American: NRXS), a pioneering medical technology company, is set to showcase its advances in neuromodulation therapies at the upcoming Lytham Partners Fall 2024 Investor Conference. This significant event, which focuses on innovations aimed at addressing chronic conditions, will take place virtually on a designated date in the early autumn.
Insightful Webcast Presentation
The highlight of the conference will be a webcasted presentation from NeurAxis scheduled for 12:30 p.m. ET. Attendees are encouraged to tune in to gain insights into the company's innovative solutions and future directions in neuromodulation therapies. The webcast will be available online, allowing viewers to participate from anywhere.
Opportunity for One-on-One Meetings
In addition to the presentation, NeurAxis management will engage in virtual one-on-one meetings throughout the event. Investors who wish to discuss the company’s vision and strategies directly are invited to schedule these meetings. Such interactions provide a unique opportunity to delve deeper into NeurAxis's operations and goals.
About NeurAxis and Its Innovative Therapies
NeurAxis is dedicated to developing neuromodulation therapies targeting debilitating conditions affecting both children and adults. The company’s flagship IB-Stim™ therapy employs its cutting-edge Percutaneous Electrical Nerve Field Stimulation technology, which has received FDA clearance specifically for treating functional abdominal pain related to irritable bowel syndrome (IBS) in adolescents aged 11 to 18. As part of its commitment to healthcare, NeurAxis is actively conducting further clinical trials that explore applications of PENFS across various pediatric and adult conditions.
Company’s Commitment to Advancements in Medicine
NeurAxis’s overarching mission is to elevate patient care through science and evidence-based practices. The organization is unwavering in its goal to enhance the quality of life for individuals enduring chronic conditions. By focusing on innovative treatment options, NeurAxis is not just addressing existing challenges but also paving the way for future breakthroughs in medical technology.
Contacts for More Information
For those seeking additional details about NeurAxis or wishing to reach out regarding investor relations, please contact:
Company:
NeurAxis, Inc.
Email: info@neuraxis.com
Investor Relations:
Lytham Partners
Ben Shamsian
646-829-9701
Email: shamsian@lythampartners.com
Frequently Asked Questions
What is NeurAxis known for?
NeurAxis is known for its innovative work in neuromodulation therapies designed to address chronic conditions in both children and adults.
What will NeurAxis present at the conference?
NeurAxis will showcase its advancements in neuromodulation therapies, including the IB-Stim™ technology for treating abdominal pain related to IBS.
When will the webcasted presentation occur?
The webcasted presentation is scheduled for 12:30 p.m. ET on the date of the event, which will be streamed online for all attendees.
Can investors meet with NeurAxis management?
Yes, investors can arrange virtual one-on-one meetings with NeurAxis management during the conference.
How can I contact NeurAxis for more information?
You can reach NeurAxis by emailing info@neuraxis.com for company inquiries or contact Lytham Partners for investor relations at shamsian@lythampartners.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.